168 related articles for article (PubMed ID: 29259264)
1. Skin immunization by microneedle patch overcomes statin-induced suppression of immune responses to influenza vaccine.
Vassilieva EV; Wang S; Li S; Prausnitz MR; Compans RW
Sci Rep; 2017 Dec; 7(1):17855. PubMed ID: 29259264
[TBL] [Abstract][Full Text] [Related]
2. A boosting skin vaccination with dissolving microneedle patch encapsulating M2e vaccine broadens the protective efficacy of conventional influenza vaccines.
Zhu W; Pewin W; Wang C; Luo Y; Gonzalez GX; Mohan T; Prausnitz MR; Wang BZ
J Control Release; 2017 Sep; 261():1-9. PubMed ID: 28642154
[TBL] [Abstract][Full Text] [Related]
3. Improved immunogenicity of individual influenza vaccine components delivered with a novel dissolving microneedle patch stable at room temperature.
Vassilieva EV; Kalluri H; McAllister D; Taherbhai MT; Esser ES; Pewin WP; Pulit-Penaloza JA; Prausnitz MR; Compans RW; Skountzou I
Drug Deliv Transl Res; 2015 Aug; 5(4):360-71. PubMed ID: 25895053
[TBL] [Abstract][Full Text] [Related]
4. C-di-GMP with influenza vaccine showed enhanced and shifted immune responses in microneedle vaccination in the skin.
Shin JH; Lee JH; Jeong SD; Noh JY; Lee HW; Song CS; Kim YC
Drug Deliv Transl Res; 2020 Jun; 10(3):815-825. PubMed ID: 32141036
[TBL] [Abstract][Full Text] [Related]
5. Microneedle patch delivery of influenza vaccine during pregnancy enhances maternal immune responses promoting survival and long-lasting passive immunity to offspring.
Esser ES; Pulit-Penaloza JA; Kalluri H; McAllister D; Vassilieva EV; Littauer EQ; Lelutiu N; Prausnitz MR; Compans RW; Skountzou I
Sci Rep; 2017 Jul; 7(1):5705. PubMed ID: 28720851
[TBL] [Abstract][Full Text] [Related]
6. Enhanced memory responses to seasonal H1N1 influenza vaccination of the skin with the use of vaccine-coated microneedles.
Kim YC; Quan FS; Yoo DG; Compans RW; Kang SM; Prausnitz MR
J Infect Dis; 2010 Jan; 201(2):190-8. PubMed ID: 20017632
[TBL] [Abstract][Full Text] [Related]
7. Enhanced Immune Responses Conferring Cross-Protection by Skin Vaccination With a Tri-Component Influenza Vaccine Using a Microneedle Patch.
Zhu W; Li S; Wang C; Yu G; Prausnitz MR; Wang BZ
Front Immunol; 2018; 9():1705. PubMed ID: 30105019
[TBL] [Abstract][Full Text] [Related]
8. [Immune protective effectiveness of seasonal influenza spilt vaccine against homologous and heterogonous subtypes of influenza virus in mice].
Huang BY; Wang XP; Wang WL; Hu W; Gao Q; Tan WJ; Ruan L
Bing Du Xue Bao; 2011 May; 27(3):265-73. PubMed ID: 21774253
[TBL] [Abstract][Full Text] [Related]
9. Effect of zymosan and poly (I:C) adjuvants on responses to microneedle immunization coated with whole inactivated influenza vaccine.
Shin JH; Noh JY; Kim KH; Park JK; Lee JH; Jeong SD; Jung DY; Song CS; Kim YC
J Control Release; 2017 Nov; 265():83-92. PubMed ID: 28890214
[TBL] [Abstract][Full Text] [Related]
10. Microneedle delivery of trivalent influenza vaccine to the skin induces long-term cross-protection.
Kim YC; Lee SH; Choi WH; Choi HJ; Goo TW; Lee JH; Quan FS
J Drug Target; 2016 Dec; 24(10):943-951. PubMed ID: 26957023
[TBL] [Abstract][Full Text] [Related]
11. Microneedle Vaccination Elicits Superior Protection and Antibody Response over Intranasal Vaccination against Swine-Origin Influenza A (H1N1) in Mice.
Shin JH; Park JK; Lee DH; Quan FS; Song CS; Kim YC
PLoS One; 2015; 10(6):e0130684. PubMed ID: 26086590
[TBL] [Abstract][Full Text] [Related]
12. Potency of whole virus particle and split virion vaccines using dissolving microneedle against challenges of H1N1 and H5N1 influenza viruses in mice.
Nakatsukasa A; Kuruma K; Okamatsu M; Hiono T; Suzuki M; Matsuno K; Kida H; Oyamada T; Sakoda Y
Vaccine; 2017 May; 35(21):2855-2861. PubMed ID: 28431812
[TBL] [Abstract][Full Text] [Related]
13. Linear DNA vaccine prepared by large-scale PCR provides protective immunity against H1N1 influenza virus infection in mice.
Wang F; Chen Q; Li S; Zhang C; Li S; Liu M; Mei K; Li C; Ma L; Yu X
Vet Microbiol; 2017 Jun; 205():124-130. PubMed ID: 28622854
[TBL] [Abstract][Full Text] [Related]
14. Dose sparing enabled by skin immunization with influenza virus-like particle vaccine using microneedles.
Quan FS; Kim YC; Compans RW; Prausnitz MR; Kang SM
J Control Release; 2010 Nov; 147(3):326-32. PubMed ID: 20692307
[TBL] [Abstract][Full Text] [Related]
15. Increased immunogenicity of avian influenza DNA vaccine delivered to the skin using a microneedle patch.
Kim YC; Song JM; Lipatov AS; Choi SO; Lee JW; Donis RO; Compans RW; Kang SM; Prausnitz MR
Eur J Pharm Biopharm; 2012 Jun; 81(2):239-47. PubMed ID: 22504442
[TBL] [Abstract][Full Text] [Related]
16. Enhanced Stability of Inactivated Influenza Vaccine Encapsulated in Dissolving Microneedle Patches.
Chu LY; Ye L; Dong K; Compans RW; Yang C; Prausnitz MR
Pharm Res; 2016 Apr; 33(4):868-78. PubMed ID: 26620313
[TBL] [Abstract][Full Text] [Related]
17. A viable recombinant rhabdovirus lacking its glycoprotein gene and expressing influenza virus hemagglutinin and neuraminidase is a potent influenza vaccine.
Ryder AB; Buonocore L; Vogel L; Nachbagauer R; Krammer F; Rose JK
J Virol; 2015 Mar; 89(5):2820-30. PubMed ID: 25540378
[TBL] [Abstract][Full Text] [Related]
18. Efficacy of A/H1N1/2009 split inactivated influenza A vaccine (GC1115) in mice and ferrets.
Han HJ; Song MS; Park SJ; Byun HY; Robles NJC; Ha SH; Choi YK
J Microbiol; 2019 Feb; 57(2):163-169. PubMed ID: 30706345
[TBL] [Abstract][Full Text] [Related]
19. Transdermal influenza immunization with vaccine-coated microneedle arrays.
Koutsonanos DG; del Pilar Martin M; Zarnitsyn VG; Sullivan SP; Compans RW; Prausnitz MR; Skountzou I
PLoS One; 2009; 4(3):e4773. PubMed ID: 19274084
[TBL] [Abstract][Full Text] [Related]
20. A new adjuvanted nanoparticle-based H1N1 influenza vaccine induced antigen-specific local mucosal and systemic immune responses after administration into the lung.
Neuhaus V; Chichester JA; Ebensen T; Schwarz K; Hartman CE; Shoji Y; Guzmán CA; Yusibov V; Sewald K; Braun A
Vaccine; 2014 May; 32(26):3216-22. PubMed ID: 24731807
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]